Search

Bure Equity AB

Закрыт

278.6 -1.21

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

278

Макс.

279

Ключевые показатели

By Trading Economics

Доход

1.4B

-1.2B

Продажи

136M

195M

P/E

Средняя по отрасли

199.72

27.54

Прибыль на акцию

-16.845

Дивидендная доходность

0.97

Рентабельность продаж

-640.513

Сотрудники

11

EBITDA

1.4B

-1.2B

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

0.97%

3.88%

Следующий отчет о доходах

6 нояб. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

889M

22B

Предыдущая цена открытия

279.81

Предыдущая цена закрытия

278.6

Bure Equity AB График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

1 нояб. 2025 г., 12:56 UTC

Отчет

Berkshire's Quarterly Earnings Rise After Insurance Results Improve -- WSJ

1 нояб. 2025 г., 12:56 UTC

Отчет
Приобретения, слияния, поглощения

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 нояб. 2025 г., 12:20 UTC

Отчет
Приобретения, слияния, поглощения

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 нояб. 2025 г., 12:19 UTC

Отчет
Приобретения, слияния, поглощения

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 нояб. 2025 г., 08:20 UTC

Обсуждения рынка

Financial Services Roundup: Market Talk

1 нояб. 2025 г., 08:20 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

1 нояб. 2025 г., 05:00 UTC

Отчет
Приобретения, слияния, поглощения

Berkshire Hathaway Probably Had a Stellar Quarter. Stock Buybacks Are a Wild Card. -- Barrons.com

1 нояб. 2025 г., 00:10 UTC

Отчет

Trouble on The Strip -- Barrons.com

31 окт. 2025 г., 23:09 UTC

Отчет

Review & Preview: October Surprise -- Barrons.com

31 окт. 2025 г., 22:44 UTC

Приобретения, слияния, поглощения

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 окт. 2025 г., 21:25 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

31 окт. 2025 г., 21:20 UTC

Приобретения, слияния, поглощения

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

31 окт. 2025 г., 21:12 UTC

Приобретения, слияния, поглощения

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

31 окт. 2025 г., 21:12 UTC

Приобретения, слияния, поглощения

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 окт. 2025 г., 21:12 UTC

Приобретения, слияния, поглощения

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

31 окт. 2025 г., 20:51 UTC

Приобретения, слияния, поглощения

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

31 окт. 2025 г., 20:50 UTC

Обсуждения рынка

Financial Services Roundup: Market Talk

31 окт. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

31 окт. 2025 г., 20:50 UTC

Обсуждения рынка
Отчет

Auto & Transport Roundup: Market Talk

31 окт. 2025 г., 20:46 UTC

Приобретения, слияния, поглощения

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

31 окт. 2025 г., 20:22 UTC

Отчет

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

31 окт. 2025 г., 20:02 UTC

Отчет

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

31 окт. 2025 г., 19:55 UTC

Обсуждения рынка

Crude Futures Fall for Third Straight Month -- Market Talk

31 окт. 2025 г., 19:54 UTC

Приобретения, слияния, поглощения

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

31 окт. 2025 г., 19:54 UTC

Приобретения, слияния, поглощения

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

31 окт. 2025 г., 19:26 UTC

Обсуждения рынка

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

31 окт. 2025 г., 18:30 UTC

Отчет

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

31 окт. 2025 г., 18:23 UTC

Обсуждения рынка

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

31 окт. 2025 г., 18:09 UTC

Отчет

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31 окт. 2025 г., 18:08 UTC

Отчет

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

Bure Equity AB Прогноз

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Bure Equity AB

Bure Equity AB (publ) is a private equity and venture capital firm specializing in secondary direct, later stage, middle market, mature, buyouts, emerging growth, expansion capital, mid venture, late venture, PIPES, bridge, industry consolidation, recapitalizations, growth capital, special situation and turnarounds. The firm has agnostic approach and seeks to invest in listed and unlisted SME companies and assets in knowledge driven service companies. It primarily invests in education service companies, communication services, medtech, consumer staples, financials, industrials, healthcare, information technology, and professional services. The firm prefers to invest in Nordic and European developed markets. It invests between $5 million to $100 million. The firm seeks to be a principal shareholder with a controlling influence in the portfolio company. The firm takes majority stake. The firm has no established exit strategy but prefers to hold its investment for a period of three to five years. It invests through its own balance sheet. Bure Equity AB (publ) was founded on November 23, 1992 and is based in Stockholm, Sweden.
help-icon Live chat